New knee osteoarthritis treatment shows promise in early human test
NCT ID NCT06539429
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This early-phase trial is testing a new biological treatment called ANT-301 in 6 people with severe knee osteoarthritis. The main goal is to check safety, but researchers will also measure pain and knee function. If safe, larger studies could follow to see if it truly helps.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ANT-301 (a biological product made from cells)
- What this could lead to
- If it works, this could point toward a new treatment to control knee osteoarthritis pain and improve function.
- What could go wrong
- This is a very early, tiny trial with only 6 people. It mainly checks safety, not effectiveness. The treatment may not work or could have side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOARTHRITIS, KNEE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Seoul National University
Seoul, Seoul, 03080, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a common painkiller sabotage your knee treatment?
- Can a Mind-Body program ease knee pain and lift mood?
- Which knee implant feels more natural? a trial puts two designs to the test
- Could a quick insulin shot stop Steroid-Induced blood sugar spikes?
- Which Nerve-Blocking technique offers better knee pain relief?
- Knee replacement pain: can a simple injection match a nerve block?